Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases.
Se Young JangWon Young TakSoo-Young ParkYoung Oh KweonYu Rim LeeGyeong Hwa KimKeun HurMan-Hoon HanWon Kee LeePublished in: Annals of laboratory medicine (2021)
The serum M2BPGi level increased with liver fibrosis severity and could be a good biomarker for diagnosing advanced fibrosis and cirrhosis in NAFLD patients. A well-controlled, prospective study with a larger sample size is needed to validate the diagnostic power of M2BPGi and other fibrosis markers in NAFLD.